LYRA - Lyra Therapeutics, Inc.
1.2783
-0.012 -0.915%
Share volume: 14,714
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.29
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 04-30-2024 | 08-14-2024 | 11-12-2024 | 03-13-2025 | 05-06-2025 | 11-12-2025 | |
| Total revenue | 532.000 K | 598.000 K | 195.000 K | 209.000 K | 183.000 K | 25.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 532.000 K | 598.000 K | 195.000 K | 209.000 K | 183.000 K | 25.000 K | |
| 12.41% | -67.39% | 7.18% | -12.44% | -86.34% | |||
| Operating expenses | 24.056 M | 18.403 M | 9.833 M | 9.975 M | 8.139 M | 6.283 M | |
| Selling general and admin | 5.818 M | 5.139 M | 3.931 M | 3.613 M | 3.263 M | 2.236 M | |
| Research and development | 18.238 M | 13.264 M | 5.902 M | 6.362 M | 4.876 M | 4.047 M | |
| Total expenses | 24.056 M | 49.572 M | 14.537 M | 9.717 M | 9.024 M | 6.262 M | |
| 106.07% | -70.67% | -33.16% | -7.13% | -30.61% | |||
| Operating income | -23.524 M | -48.974 M | -12.442 M | -11.408 M | -8.841 M | -6.237 M | |
| Ebit | -23.524 M | -48.974 M | -12.442 M | -11.408 M | -8.841 M | -6.237 M | |
| Pretax income | -22.438 M | -48.119 M | -11.866 M | -10.973 M | -8.543 M | -5.981 M | |
| 114.45% | -75.34% | -7.53% | -22.15% | -29.99% | |||
| Income tax | 14.000 K | 12.000 K | 7.000 K | 6.000 K | 4.000 K | 3.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -22.452 M | -48.131 M | -13.773 M | -9.079 M | -8.547 M | -5.984 M | |
| -114.37% | 71.38% | 34.08% | 5.86% | 29.99% |